| Sansano M, Reynard AM, Cunningham RK; Inhibition of serum bactericidal reaction by lipopolysaccharide.; Infect Immun; 1985 Jun; 48(3); 759-762 |
| Dutcher BS, Reynard AM, Beck ME, Cunningham RK; Potentiation of antibiotic bactericidal activity by normal human serum.; Antimicrob Agents Chemother; 1978 May; 13(5); 820-826 |
| Reynard AM, Beck ME, Cunningham RK; Effects of antibiotic resistance plasmids on the bactericidal activity of normal rabbit serum.; Infect Immun; 1978 Mar; 19(3); 861-866 |
| Eckerson HW, Reynard AM; Effect of entry exclusion on mating aggregates and transconjugants.; J Bacteriol; 1977 Jan; 129(1); 131-137 |
| Reynard AM, Beck ME; Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum.; Infect Immun; 1976 Sep; 14(3); 848-850 |
| Camiolo SM, Beck ME, Reynard AM; Tetracycline resistance in Escherichia coli isolates from hospital patients.; Antimicrob Agents Chemother; 1975 Oct; 8(4); 488-494 |
| Reynard AM, Nellis LF; Uptake of tetracycline by Escherichia coli: lack of binding of tetracycline to the uptake system.; Biochem Biophys Res Commun; 1972 Sep; 48(5); 1129-1132 |
| Bakhle YS, Reynard AM; Characteristics of the angiotensin I converting enzyme from dog lung.; Nat New Biol; 1971 Feb; 229(6); 187-189 |
| Reynard AM, Nellis LF, Beck ME; Uptake of 3H-Tetracycline by resistant and sensitive Escherichia coli.; Appl Microbiol; 1971 Jan; 21(1); 71-75 |
| Bakhle YS, Reynard AM, Vane JR; Metabolism of the angiotensins in isolated perfused tissues.; Nature; 1969 Jun; 222(197); 956-959 |
| Reynard AM; The reversible and irreversible inhibition of N1-methylnicotinamide uptake into rat kidney cortex slices.; J Pharmacol Exp Ther; 1968 Oct; 163(2); 461-467 |
| Reynard AM; N1-methylnicotinamide uptake by rat kidney slices: reversible and irreversible inhibition.; Br J Pharmacol; 1968 Sep; 34(1); 190-191 |
| Kennedy WJ, Reynard AM; Decreased conjugation efficiency by Fla-mutants of Escherichia coli K-12 bearing F-like plasmids.; Microbios; 22(89-90); 173-183 |
| Reynard AM; The regulation of complement activity by pharmacologic agents.; J Immunopharmacol; 2(1); 1-47 |